RESUMEN
Wolfram syndrome (WS) is an ultra-rare progressive neurodegenerative disorder defined by early-onset diabetes mellitus and optic atrophy. The majority of patients harbour recessive mutations in the WFS1 gene, which encodes for Wolframin, a transmembrane endoplasmic reticulum protein. There is limited availability of human ocular and brain tissues, and there are few animal models for WS that replicate the neuropathology and clinical phenotype seen in this disorder. We, therefore, characterised two wfs1 zebrafish knockout models harbouring nonsense wfs1a and wfs1b mutations. Both homozygous mutant wfs1a-/- and wfs1b-/- embryos showed significant morphological abnormalities in early development. The wfs1b-/- zebrafish exhibited a more pronounced neurodegenerative phenotype with delayed neuronal development, progressive loss of retinal ganglion cells and clear evidence of visual dysfunction on functional testing. At 12 months of age, wfs1b-/- zebrafish had a significantly lower RGC density per 100 µm2 (mean ± standard deviation; 19 ± 1.7) compared with wild-type (WT) zebrafish (25 ± 2.3, p < 0.001). The optokinetic response for wfs1b-/- zebrafish was significantly reduced at 8 and 16 rpm testing speeds at both 4 and 12 months of age compared with WT zebrafish. An upregulation of the unfolded protein response was observed in mutant zebrafish indicative of increased endoplasmic reticulum stress. Mutant wfs1b-/- zebrafish exhibit some of the key features seen in patients with WS, providing a versatile and cost-effective in vivo model that can be used to further investigate the underlying pathophysiology of WS and potential therapeutic interventions.
Asunto(s)
Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Síndrome de Wolfram/genética , Síndrome de Wolfram/fisiopatología , Animales , Codón sin Sentido , Modelos Animales de Enfermedad , Técnicas de Inactivación de Genes , Mutación , Atrofia Óptica , Respuesta de Proteína Desplegada , Síndrome de Wolfram/metabolismo , Pez CebraRESUMEN
BACKGROUND: Joubert syndrome and related disorders (JSRD) and Jeune syndrome are multisystem ciliopathy disorders with overlapping phenotypes. There are a growing number of genetic causes for these rare syndromes, including the recently described genes ARL3 and CEP120. METHODS: We sought to explore the developmental expression patterns of ARL3 and CEP120 in humans to gain additional understanding of these genetic conditions. We used an RNA in situ detection technique called RNAscope to characterise ARL3 and CEP120 expression patterns in human embryos and foetuses in collaboration with the MRC-Wellcome Trust Human Developmental Biology Resource. RESULTS: Both ARL3 and CEP120 are expressed in early human brain development, including the cerebellum and in the developing retina and kidney, consistent with the clinical phenotypes seen with pathogenic variants in these genes. CONCLUSIONS: This study provides insights into the potential pathogenesis of JSRD by uncovering the spatial expression of two JSRD-causative genes during normal human development.
Asunto(s)
Factores de Ribosilacion-ADP/genética , Proteínas de Ciclo Celular/genética , Ciliopatías/genética , Regulación del Desarrollo de la Expresión Génica , Factores de Ribosilacion-ADP/metabolismo , Encéfalo/crecimiento & desarrollo , Encéfalo/metabolismo , Proteínas de Ciclo Celular/metabolismo , Ciliopatías/patología , Ciliopatías/fisiopatología , Ganglios Espinales/crecimiento & desarrollo , Ganglios Espinales/metabolismo , Humanos , Riñón/crecimiento & desarrollo , Riñón/metabolismo , Mutación , Fenotipo , Retina/crecimiento & desarrollo , Retina/metabolismoRESUMEN
Calcium oxalate (CaOx) crystal deposition within the tubules is often a perplexing finding on renal biopsy of both native and transplanted kidneys. Understanding the underlying causes may help diagnosis and future management. The most frequent cause of CaOx crystal deposition within the kidney is hyperoxaluria. When this is seen in native kidney biopsy, primary hyperoxaluria must be considered and investigated further with biochemical and genetic tests. Secondary hyperoxaluria, for example due to enteric hyperoxaluria following bariatric surgery, ingested ethylene glycol or vitamin C overdose may also cause CaOx deposition in native kidneys. CaOx deposition is a frequent finding in renal transplant biopsy, often as a consequence of acute tubular necrosis and is associated with poorer long-term graft outcomes. CaOx crystal deposition in the renal transplant may also be secondary to any of the causes associated with this phenotype in the native kidney. The pathophysiology underlying CaOx deposition is complex but this histological phenotype may indicate serious underlying pathology and should always warrant further investigation.
Asunto(s)
Oxalato de Calcio/metabolismo , Hiperoxaluria/metabolismo , Riñón/metabolismo , Humanos , Hiperoxaluria/complicaciones , Hiperoxaluria/diagnóstico , Hiperoxaluria/etiologíaRESUMEN
Nephronophthisis-related ciliopathies (NPHP-RC) are a group of inherited genetic disorders that share a defect in the formation, maintenance or functioning of the primary cilium complex, causing progressive cystic kidney disease and other clinical manifestations. Mutations in centrosomal protein 164 kDa (CEP164), also known as NPHP15, have been identified as a cause of NPHP-RC. Here we have utilised the MRC-Wellcome Trust Human Developmental Biology Resource (HDBR) to perform immunohistochemistry studies on human embryonic and foetal tissues to determine the expression patterns of CEP164 during development. Notably expression is widespread, yet defined, in multiple organs including the kidney, retina and cerebellum. Murine studies demonstrated an almost identical Cep164 expression pattern. Taken together, these data support a conserved role for CEP164 throughout the development of numerous organs, which, we suggest, accounts for the multi-system disease phenotype of CEP164-mediated NPHP-RC.
Asunto(s)
Cilios/genética , Ciliopatías/genética , Enfermedades Renales Quísticas/genética , Proteínas de Microtúbulos/genética , Animales , Cilios/patología , Ciliopatías/patología , Modelos Animales de Enfermedad , Feto/metabolismo , Regulación del Desarrollo de la Expresión Génica/genética , Humanos , Riñón/metabolismo , Riñón/patología , Enfermedades Renales Quísticas/patología , Ratones , Retina/metabolismo , Retina/patologíaRESUMEN
BACKGROUND: Inherited renal disorders comprise a significant proportion of cases in both paediatric and adult nephrology services. Genetic advances have advanced rapidly while clinical models of care delivery have remained static. AIM: To describe a cohort of patients attending a multidisciplinary renal genetics clinic and the insights gained from this experience. DESIGN AND METHODS: A retrospective review of clinic cases and their molecular genetic diagnosis over a 5-year period. RESULTS: We report details of 244 individuals including 80 probands who attended the clinic. The commonest reasons for referral was familial haematuria which accounted for 37.5% of cases and cystic kidney disease, accounting for 31% of cases. Eighteen probands had a known molecular genetic diagnosis and were referred for genetic counselling and screening of at risk relatives and management plans. About 62 probands and their families were referred for a precise molecular diagnosis and this was achieved in 26 cases (42%). The most frequent new genetic diagnoses were COL4A5 mutations underlying familial haematuria and familial end stage renal disease. The clinic also allowed for patients with rare renal syndromes to be reviewed, such as ciliopathy syndromes, allowing detailed phenotyping and often a precise molecular genetic diagnosis to be provided. CONCLUSIONS: The integration of modern day genetics and genomics into multidisciplinary clinics often allows a precise diagnosis which benefits patients, their relatives and the clinicians providing care and future management.
Asunto(s)
Colágeno Tipo IV/genética , Hematuria/genética , Fallo Renal Crónico/genética , Adolescente , Adulto , Instituciones de Atención Ambulatoria , Niño , Preescolar , Diagnóstico Diferencial , Femenino , Asesoramiento Genético , Pruebas Genéticas , Hematuria/diagnóstico , Humanos , Lactante , Recién Nacido , Enfermedades Renales Quísticas/diagnóstico , Enfermedades Renales Quísticas/epidemiología , Fallo Renal Crónico/diagnóstico , Masculino , Persona de Mediana Edad , Mutación , Derivación y Consulta , Estudios Retrospectivos , Reino Unido , Adulto JovenRESUMEN
Glanzmann thrombasthenia (GT) is an inherited genetic disorder affecting platelets, which is characterized by spontaneous mucocutaneous bleeding and abnormally prolonged bleeding in response to injury or trauma. The underlying defect is failure of platelet aggregation due to qualitative and/or quantitative deficiency of platelet integrin αIIbß3 resulting from molecular genetic defects in either ITGA2B or ITGB3. Here, we examine a Pakistani cohort of 15 patients with clinical symptoms of GT who underwent laboratory and molecular genetic analysis. In patients with a broad range of disease severity and age of presentation, we identified pathogenic mutations in ITGA2B in 11 patients from 8 different families, including 2 novel homozygous mutations and 1 novel heterozygous mutation. Mutations in ITGB3 were identified in 4 patients from 3 families, two of which were novel homozygous truncating mutations. A molecular genetic diagnosis was established in 11 families with GT, including 5 novel mutations extending the spectrum of mutations in this disease within a region of the world where little is known about the incidence of GT. Mutational analysis is a key component of a complete diagnosis of GT and allows appropriate management and screening of other family members to be performed.
Asunto(s)
Mutación Missense/genética , Trombastenia/genética , Adolescente , Niño , Preescolar , Estudios de Cohortes , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Modelos Moleculares , PakistánRESUMEN
Autosomal recessive polycystic kidney disease (ARPKD) is an inherited ciliopathy leading to progressive kidney and liver disease. Biallelic mutations in the PKHD1 gene underlie this condition. We describe a child with bilaterally enlarged cystic kidneys, portal hypertension, and cerebral ventriculomegaly. Molecular genetic investigations using whole-exome sequencing and confirmation using Sanger sequencing revealed a homozygous pathogenic mutation in PKHD1 underlying the clinical phenotype of ARPKD. Whole-exome data analysis was used to search for additional rare variants in additional ciliopathy genes that may have contributed to the unusual brain phenotype. Aside from a rare hypomorphic allele in MKS1, no other pathogenic variants were detected. We conclude that the homozygous pathogenic mutation in PKHD1 underlies the ciliopathy phenotype in this patient.
Asunto(s)
Exoma/genética , Hidrocefalia/genética , Mutación Missense , Riñón Poliquístico Autosómico Recesivo/genética , Receptores de Superficie Celular/genética , Secuencia de Bases , Preescolar , Análisis Mutacional de ADN/métodos , Femenino , Homocigoto , Humanos , Hidrocefalia/patología , Riñón Poliquístico Autosómico Recesivo/patologíaAsunto(s)
Enfermedad de Fabry/diagnóstico , Enfermedad de Fabry/genética , Adulto , Terapia de Reemplazo Enzimático/métodos , Enfermedad de Fabry/complicaciones , Enfermedad de Fabry/tratamiento farmacológico , Genotipo , Cardiopatías/diagnóstico , Cardiopatías/etiología , Cardiopatías/genética , Humanos , Fallo Renal Crónico/etiología , Fallo Renal Crónico/genética , Imagen por Resonancia Magnética , Masculino , Mutación , Linaje , Fenotipo , HermanosAsunto(s)
Calcinosis/etiología , Hiperparatiroidismo Secundario/complicaciones , Fallo Renal Crónico/complicaciones , Enfermedades Vasculares/etiología , Calcinosis/diagnóstico por imagen , Femenino , Mano/diagnóstico por imagen , Humanos , Hiperparatiroidismo Secundario/tratamiento farmacológico , Cumplimiento de la Medicación , Persona de Mediana Edad , Radiografía , Diálisis Renal , Enfermedades Vasculares/diagnóstico por imagenRESUMEN
Extracellular pyrophosphate (PPi) plays a central role in the control of normal bone mineralization since it antagonizes inorganic phosphate in the promotion of hydroxyapatite deposition. Studies using knock-out mice have established the functional importance of PPi generation via nucleotide pyrophosphatase phosphodiesterases (NPP) and of PPi transmembrane transport by the progressive ankylosis (ANK) protein. Tissue non-specific alkaline phosphatase activity counteracts this by hydrolysis of PPi to inorganic phosphate. The molecular nature and transport function of ANK are reviewed. A close parallel is drawn between the controlled mineralization of bone and the prevention of abnormal calcium crystal deposition within the kidney, especially when concentrated urine is produced. Pyrophosphate is present in urine, and ANK is expressed in the cortical collecting duct where PPi transport to both the tubular lumen and the renal interstitium may occur. Pyrophosphate may also be generated here by nucleoside triphosphate diphosphohydrolases (NTPD2 and 3) together with NPP1. Alkaline phosphatase activity is restricted to the proximal nephron, remote from these sites of PPi generation, transport and function. The physiological importance of PPi generation and transport in preventing idiopathic calcium renal stone disease and nephrocalcinosis now needs to be established.
Asunto(s)
Calcificación Fisiológica/fisiología , Cálculos Renales/fisiopatología , Animales , Calcificación Fisiológica/efectos de los fármacos , Difosfatos/metabolismo , Humanos , Articulaciones/crecimiento & desarrollo , Articulaciones/fisiología , Riñón/metabolismo , Cálculos Renales/tratamiento farmacológicoRESUMEN
Joubert syndrome (JS) is an autosomal recessive disorder, consisting of mental retardation, cerebellar vermis aplasia, an irregular breathing pattern, and retinal degeneration. Nephronophthisis (NPHP) is found in 17-27% of these patients, which was designated JS type B. Mutations in four separate genes (AHI1, NPHP1, CEP290/NPHP6, and MKS3) are linked to JS. However, missense mutations in a new ciliary gene (RPGRIP1L) were found in type B patients. We analyzed a cohort of 56 patients with JS type B who were negative for mutations in three (AHI1, NPHP1, and CEP290/NPHP6) of the four genes previously linked to the syndrome. The 26 exons encoding RPGRIP1L were analyzed by means of PCR amplification, CEL I endonuclease digestion, and subsequent sequencing. Using this approach, four different mutations in the RPGRIP1L gene in five different families were identified and three were found to be novel mutations. Additionally, we verified that missense mutations are responsible for JS type B and cluster in exon 15 of the RPGRIP1L gene. Our studies confirm that a T615P mutation represents the most common mutation in the RPGRIP1L gene causing disease in about 8-10% of JS type B patients negative for NPHP1, NPHP6, or AHI1 mutations.